Skip to main content
Premium Trial:

Request an Annual Quote

Elias Zerhouni, John Leamon, Peter Amanatides

Premium
National Institutes of Health Director Elias Zerhouni will resign from his position at the end of October "to pursue writing projects and explore other professional opportunities." Raynard Kington, deputy director of NIH, will likely serve as acting director until a new administration names his successor. Zerhouni was appointed to the directorship of NIH in 2002 by President George W. Bush.
 

 
John Leamon has become director of molecular biology at Ion Torrent Systems in Guilford, Conn. He joined the company from RainDance Technologies, where he was a project leader.
 

 

Peter Amanatides has become vice president of quality assurance and quality control for Noven Pharmaceuticals. Prior to Noven, he held several senior positions at DSM Pharmaceuticals. Before that, he was director of quality systems at Celera Genomics. Amanatides holds an MS in biotechnology and molecular biology from Hood College and a BS in biology from Regents College.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.